205 related articles for article (PubMed ID: 35563270)
1. CfDNA Measurement as a Diagnostic Tool for the Detection of Brain Somatic Mutations in Refractory Epilepsy.
Mayo S; Gómez-Manjón I; Fernández-Martínez FJ; Camacho A; Martínez F; Benito-León J
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563270
[TBL] [Abstract][Full Text] [Related]
2. Detection of Brain Somatic Mutations in Cerebrospinal Fluid from Refractory Epilepsy Patients.
Kim S; Baldassari S; Sim NS; Chipaux M; Dorfmüller G; Kim DS; Chang WS; Taly V; Lee JH; Baulac S
Ann Neurol; 2021 Jun; 89(6):1248-1252. PubMed ID: 33834539
[TBL] [Abstract][Full Text] [Related]
3. Detection of mutational patterns in cell-free DNA of colorectal cancer by custom amplicon sequencing.
Herrmann S; Zhan T; Betge J; Rauscher B; Belle S; Gutting T; Schulte N; Jesenofsky R; Härtel N; Gaiser T; Hofheinz RD; Ebert MP; Boutros M
Mol Oncol; 2019 Aug; 13(8):1669-1683. PubMed ID: 31254442
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency.
Bustamante Alvarez JG; Janse S; Owen DH; Kiourtsis S; Bertino EM; He K; Carbone DP; Otterson GA
Clin Lung Cancer; 2021 Jul; 22(4):e519-e527. PubMed ID: 33414052
[TBL] [Abstract][Full Text] [Related]
5. From cfDNA to Sequencing: Workflows and Potentials.
Tebaldi M; Salvi S
Methods Mol Biol; 2019; 1909():119-125. PubMed ID: 30580427
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Yield of Epilepsy Panels in Children With Medication-Refractory Epilepsy.
Segal E; Pedro H; Valdez-Gonzalez K; Parisotto S; Gliksman F; Thompson S; Sabri J; Fertig E
Pediatr Neurol; 2016 Nov; 64():66-71. PubMed ID: 27726903
[TBL] [Abstract][Full Text] [Related]
7. Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing.
Chen E; Cario CL; Leong L; Lopez K; Márquez CP; Li PS; Oropeza E; Tenggara I; Cowan J; Simko JP; Kageyama R; Wells DK; Chan JM; Friedlander T; Aggarwal R; Paris PL; Feng F; Carroll PR; Witte JS
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250416
[TBL] [Abstract][Full Text] [Related]
8. Validation of targeted next-generation sequencing of cell-free DNA from archival cerebrospinal fluid specimens for the detection of somatic variants in cancer involving the leptomeninges: Cytopathologic and radiographic correlation.
Neil AJ; Chukwueke UN; Hoover N; Marris SRN; Rojas-Rudilla V; Manning DK; Mito JK; Cibas ES; Sholl LM
Cancer Cytopathol; 2024 Apr; 132(4):214-223. PubMed ID: 37812603
[TBL] [Abstract][Full Text] [Related]
9. Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion
Vidula N; Rich TA; Sartor O; Yen J; Hardin A; Nance T; Lilly MB; Nezami MA; Patel SP; Carneiro BA; Fan AC; Brufsky AM; Parker BA; Bridges BB; Agarwal N; Maughan BL; Raymond VM; Fairclough SR; Lanman RB; Bardia A; Cristofanilli M
Clin Cancer Res; 2020 Jun; 26(11):2546-2555. PubMed ID: 32034076
[TBL] [Abstract][Full Text] [Related]
10. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A
Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953
[No Abstract] [Full Text] [Related]
11. Analysis of Driver Mutational Hot Spots in Blood-Derived Cell-Free DNA of Patients with Primary Central Nervous System Lymphoma Obtained before Intracerebral Biopsy.
Montesinos-Rongen M; Brunn A; Tuchscherer A; Borchmann P; Schorb E; Kasenda B; Altmüller J; Illerhaus G; Ruge MI; Maarouf M; Büttner R; Hansmann ML; Hallek M; Prinz M; Siebert R; Deckert M
J Mol Diagn; 2020 Oct; 22(10):1300-1307. PubMed ID: 32745612
[TBL] [Abstract][Full Text] [Related]
12. Identification of Somatic Mutations in Thirty-year-old Serum Cell-free DNA From Patients With Breast Cancer: A Feasibility Study.
Ritter M; Paradiso V; Widmer P; Garofoli A; Quagliata L; Eppenberger-Castori S; Soysal SD; Muenst S; Ng CKY; Piscuoglio S; Weber W; Weber WP
Clin Breast Cancer; 2020 Oct; 20(5):413-421.e1. PubMed ID: 32650988
[TBL] [Abstract][Full Text] [Related]
13. The utility of cerebrospinal fluid-derived cell-free DNA in molecular diagnostics for the
Chen WL; Pao E; Owens J; Glass I; Pritchard C; Shirts BH; Lockwood C; Mirzaa GM
Cold Spring Harb Mol Case Stud; 2022 Apr; 8(3):. PubMed ID: 35483878
[TBL] [Abstract][Full Text] [Related]
14. Statistical analysis of mutant allele frequency level of circulating cell-free DNA and blood cells in healthy individuals.
Xia L; Li Z; Zhou B; Tian G; Zeng L; Dai H; Li X; Liu C; Lu S; Xu F; Tu X; Deng F; Xie Y; Huang W; He J
Sci Rep; 2017 Aug; 7(1):7526. PubMed ID: 28790338
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of next generation sequencing-liquid biopsy on cell-free DNA as a novel non-invasive diagnostic tool for Klippel-Trenaunay syndrome.
Palmieri M; Pinto AM; di Blasio L; Currò A; Monica V; Sarno LD; Doddato G; Baldassarri M; Frullanti E; Giliberti A; Mussolin B; Fallerini C; Molinaro F; Vaghi M; Renieri A; Primo L
Vascular; 2021 Feb; 29(1):85-91. PubMed ID: 32588787
[TBL] [Abstract][Full Text] [Related]
16. MET somatic activating mutations are responsible for lymphovenous malformation and can be identified using cell-free DNA next generation sequencing liquid biopsy.
Palmieri M; Di Sarno L; Tommasi A; Currò A; Doddato G; Baldassarri M; Frullanti E; Giliberti A; Fallerini C; Arzini A; Pinto A; Vaghi M; Renieri A
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):740-744. PubMed ID: 32858245
[TBL] [Abstract][Full Text] [Related]
17. Performance comparison of two next-generation sequencing panels to detect actionable mutations in cell-free DNA in cancer patients.
Macías M; Cañada-Higueras E; Alegre E; Bielsa A; Gracia J; Patiño-García A; Ferrer-Costa R; Sendino T; Andueza MP; Mateos B; Rodríguez J; Corral J; Gúrpide A; Lopez-Picazo JM; Perez-Gracia JL; Gil-Bazo I; Alkorta-Aranburu G; González Á
Clin Chem Lab Med; 2020 Jul; 58(8):1341-1348. PubMed ID: 32623849
[TBL] [Abstract][Full Text] [Related]
18. Precise detection of low-level somatic mutation in resected epilepsy brain tissue.
Sim NS; Ko A; Kim WK; Kim SH; Kim JS; Shim KW; Aronica E; Mijnsbergen C; Spliet WGM; Koh HY; Kim HD; Lee JS; Kim DS; Kang HC; Lee JH
Acta Neuropathol; 2019 Dec; 138(6):901-912. PubMed ID: 31377847
[TBL] [Abstract][Full Text] [Related]
19. Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic Acid.
Mehrotra M; Singh RR; Chen W; Huang RSP; Almohammedsalim AA; Barkoh BA; Simien CM; Hernandez M; Behrens C; Patel KP; Routbort MJ; Broaddus RR; Medeiros LJ; Wistuba II; Kopetz S; Luthra R
J Mol Diagn; 2017 Jul; 19(4):514-524. PubMed ID: 28506684
[TBL] [Abstract][Full Text] [Related]
20. cfSNV: a software tool for the sensitive detection of somatic mutations from cell-free DNA.
Li S; Hu R; Small C; Kang TY; Liu CC; Zhou XJ; Li W
Nat Protoc; 2023 May; 18(5):1563-1583. PubMed ID: 36849599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
